Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

Published:2009-09-08 Issue:7 Volume:101 Page:1059-1065
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Kosmas C,Mylonakis N,Tsakonas G,Vorgias G,Karvounis N,Tsavaris N,Daladimos T,Kalinoglou N,Malamos N,Akrivos T,Karabelis A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605305.pdf

Reference34 articles.

1. Buda A, Fossati R, Colombo N, Fei F, Floriani I, Gueli Alletti D, Katsaros D, Landoni F, Lissoni A, Malzoni C, Sartori E, Scollo P, Torri V, Zola P, Mangioni C (2005) Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol 23: 4137–4145

2. Bunnell CA, Thompson L, Buswell L, Berkowitz R, Muto M, Sheets E, Shulman LN (1998) A phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. Cancer 82: 561–566

3. Cervellino JC, Araujo CE, Pirisi C, Sanchez O, Brosto M, Rossi R (1990) Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study. Cancer Chemother Pharmacol 26 (Suppl): S1–S3

4. Choi CH, Kim TJ, Lee SJ, Lee JW, Kim BG, Lee JH, Bae DS (2006) Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix. Int J Gynecol Cancer 16: 1157–1164

5. Cox DR (1970) The Analysis of Binary Data. Methuen: London, UK

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes;Radiotherapy and Oncology;2024-06

2. Tratamiento del cáncer de cuello uterino en estadio III y IV;EMC - Ginecología-Obstetricia;2023-02

3. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation;Journal of Contemporary Brachytherapy;2022

4. Study on Signal Transduction Pathway of Migration Inhibitory Factor in Angiogenesis of Cervical Cancer;Journal of Biomaterials and Tissue Engineering;2021-09-01

5. A case of cervical adenocarcinoma admixed with neuroendocrine carcinoma successfully treated by paclitaxel and carboplatin as neoadjuvant chemotherapy;Tenri Medical Bulletin;2020-12-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3